全文获取类型
收费全文 | 4724篇 |
免费 | 217篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 90篇 |
儿科学 | 198篇 |
妇产科学 | 61篇 |
基础医学 | 471篇 |
口腔科学 | 98篇 |
临床医学 | 320篇 |
内科学 | 792篇 |
皮肤病学 | 39篇 |
神经病学 | 385篇 |
特种医学 | 334篇 |
外科学 | 897篇 |
综合类 | 125篇 |
预防医学 | 180篇 |
眼科学 | 262篇 |
药学 | 346篇 |
中国医学 | 13篇 |
肿瘤学 | 351篇 |
出版年
2023年 | 31篇 |
2022年 | 95篇 |
2021年 | 178篇 |
2020年 | 72篇 |
2019年 | 106篇 |
2018年 | 130篇 |
2017年 | 96篇 |
2016年 | 124篇 |
2015年 | 117篇 |
2014年 | 160篇 |
2013年 | 226篇 |
2012年 | 363篇 |
2011年 | 371篇 |
2010年 | 207篇 |
2009年 | 208篇 |
2008年 | 321篇 |
2007年 | 299篇 |
2006年 | 261篇 |
2005年 | 254篇 |
2004年 | 234篇 |
2003年 | 193篇 |
2002年 | 201篇 |
2001年 | 74篇 |
2000年 | 52篇 |
1999年 | 63篇 |
1998年 | 31篇 |
1997年 | 22篇 |
1996年 | 15篇 |
1995年 | 16篇 |
1993年 | 23篇 |
1992年 | 36篇 |
1991年 | 40篇 |
1990年 | 37篇 |
1989年 | 49篇 |
1988年 | 31篇 |
1987年 | 26篇 |
1986年 | 16篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 14篇 |
1982年 | 9篇 |
1981年 | 20篇 |
1980年 | 10篇 |
1979年 | 10篇 |
1976年 | 10篇 |
1975年 | 10篇 |
1974年 | 7篇 |
1973年 | 10篇 |
1972年 | 7篇 |
1971年 | 7篇 |
排序方式: 共有4962条查询结果,搜索用时 15 毫秒
101.
David R. Lynch MD PhD Massimo Pandolfo MD Jorg B. Schulz MD Susan Perlman MD Martin B. Delatycki MD PhD R. Mark Payne MD Robert Shaddy MD Kenneth H. Fischbeck MD Jennifer Farmer MS Paul Kantor MD Subha V. Raman MD Lisa Hunegs MSW MPH Joanne Odenkirchen MPH Kristy Miller MPH Petra Kaufmann MD MSC 《Movement disorders》2013,28(2):190-195
To reduce study start‐up time, increase data sharing, and assist investigators conducting clinical studies, the National Institute of Neurological Disorders and Stroke embarked on an initiative to create common data elements for neuroscience clinical research. The Common Data Element Team developed general common data elements, which are commonly collected in clinical studies regardless of therapeutic area, such as demographics. In the present project, we applied such approaches to data collection in Friedreich's ataxia (FRDA), a neurological disorder that involves multiple organ systems. To develop FRDA common data elements, FRDA experts formed a working group and subgroups to define elements in the following: ataxia and performance measures; biomarkers; cardiac and other clinical outcomes; and demographics, laboratory tests, and medical history. The basic development process included identification of international experts in FRDA clinical research, meeting by teleconference to develop a draft of standardized common data elements recommendations, vetting of recommendations across the subgroups, and dissemination of recommendations to the research community for public comment. The full recommendations were published online in September 2011 at http://www.commondataelements.ninds.nih.gov/FA.aspx . The subgroups′ recommendations are classified as core, supplemental, or exploratory. Template case report forms were created for many of the core tests. The present set of data elements should ideally lead to decreased initiation time for clinical research studies and greater ability to compare and analyze data across studies. Their incorporation into new, ongoing studies will be assessed in an ongoing fashion to define their utility in FRDA. © 2012 Movement Disorder Society 相似文献
102.
Neha Sharma Yash Gupta Meenakshi Bansal Snigdha Singh Prateek Pathak Mohd Shahbaaz Raman Mathur Jyoti Singh Mohammad Kashif Maria Grishina Vladimir Potemkin Vinoth Rajendran Poonam Prakasha Kempaiah Agam Prasad Singh Brijesh Rathi 《RSC advances》2020,10(58):35516
Malaria, a global threat to the human population, remains a challenge partly due to the fast-growing drug-resistant strains of Plasmodium species. New therapeutics acting against the pathogenic asexual and sexual stages, including liver-stage malarial infection, have now attained more attention in achieving malaria eradication efforts. In this paper, two previously identified potent antiplasmodial hydroxyethylamine (HEA) compounds were investigated for their activity against the malaria parasite''s multiple life stages. The compounds exhibited notable activity against the artemisinin-resistant strain of P. falciparum blood-stage culture with 50% inhibitory concentrations (IC50) in the low micromolar range. The compounds'' cytotoxicity on HEK293, HepG2 and Huh-7 cells exhibited selective killing activity with IC50 values > 170 μM. The in vivo efficacy was studied in mice infected with P. berghei NK65, which showed a significant reduction in the blood parasite load. Notably, the compounds were active against liver-stage infection, mainly compound 1 with an IC50 value of 1.89 μM. Mice infected with P. berghei sporozoites treated with compound 1 at 50 mg kg−1 dose had markedly reduced liver stage infection. Moreover, both compounds prevented ookinete maturation and affected the developmental progression of gametocytes. Further, systematic in silico studies suggested both the compounds have a high affinity towards plasmepsin II with favorable pharmacological properties. Overall, the findings demonstrated that HEA and piperidine possessing compounds have immense potential in treating malarial infection by acting as multistage inhibitors.Malaria, a global threat to the human population, remains a challenge partly due to the fast-growing drug-resistant strains of Plasmodium species. 相似文献
103.
104.
Aurélie Mbeutcha Ilaria Lucca Vitaly Margulis Jose A. Karam Christopher G. Wood Michela de Martino Romain Mathieu Andrea Haitel Evanguelos Xylinas Luis Kluth Morgan Rouprêt Pierre I. Karakiewicz Alberto Briganti Michael Rink Malte Rieken Alon Z. Weizer Jay D. Raman Nathalie Rioux-Leclecq Christian Bolenz Karim Bensalah Yair Lotan Christian Seitz Mesut Remzi Shahrokh F. Shariat Tobias Klatte 《World journal of urology》2016,34(8):1155-1161
Background
Excision repair cross-complementing 1 (ERCC1) has been associated with outcomes of urothelial carcinoma of the bladder, but was not yet studied in upper tract urothelial carcinoma (UTUC). The aim of this study was to assess the prognostic role of ERCC1 expression in a large international cohort of UTUC patients.Methods
Immunohistochemical ERCC1 expression was evaluated in 716 UTUC patients who underwent radical nephroureterectomy with curative intent. ERCC1 was considered positive when the H-score was >1.0. Associations with overall survival and cancer-specific survival were assessed using univariable and multivariable Cox models.Results
ERCC1 was expressed in 303 tumors (42.3 %) and linked with the presence of tumor necrosis (16.2 vs. 10.4 %, p = 0.023), but not with any other clinical or pathological variable. ERCC1 status did not predict cancer-specific survival and overall survival on both univariable (p = 0.70 and 0.32, respectively) and multivariable analyses (p = 0.48 and 0.33, respectively).Conclusions
ERCC1 is expressed in a significant proportion of UTUC and is linked with tumor necrosis, but its expression appears not to be associated with prognosis following radical nephroureterectomy.105.
106.
Muddassir Mehmood Stephanie A. Ambach Michael D. Taylor John L. Jefferies Subha V. Raman Robin J. Taylor Hemant Sawani Jacob Mathew Wojciech Mazur Kan N. Hor Hussein R. Al-Khalidi 《Pediatric cardiology》2016,37(5):878-883
The relationship between pulmonary function and right ventricle (RV) in Duchenne muscular dystrophy (DMD) has not been evaluated. Using cardiac magnetic resonance (CMR), we describe the relationship of RV size and function with spirometry in a DMD cohort. Fifty-seven boys undergoing CMR and pulmonary function testing within 1 month at a single center (2013–2015) were enrolled. Comparisons of RV ejection fraction (RVEF) and end-diastolic volume index (RVEDVI) were made across categories of percent forced vital capacity (FVC%), and relationships were assessed. Mean age was 15.5 ± 3.5 years. Spirometry and CMR were performed within 3.9 ± 4.1 days. Median FVC% was 92.0 % (67.5–116.5 %). Twenty-three (40 %) patients had abnormal FVC% (<80 %) of which 13 (57 %) had mild (FVC% 60–79 %), 6 (26 %) had moderate (FVC% 40–59 %), and 4 (17 %) had severe (FVC <40 %) reductions. Mean RVEF was 58.3 ± 3.7 %. Patients with abnormal FVC% were older and had lower RVEF and RVEDVI. Both RVEF and RVEDVI were significantly associated with FVC% (r = 0.31, p = 0.02 and r = 0.39, p = 0.003, respectively). In a large DMD cohort, RVEF and RVEDVI were related to FVC%. Worsening respiratory status may guide monitoring of cardiac function in these patients. 相似文献
107.
Murali Mahadevan FRACS Graeme van der Meer MBChB MMed Maayan Gruber MD Peter Reed DPhil Conor Jackson FRCS Colin Brown FRACS Nikki Mills FRACS Lesley J. Salkeld FRACS FRCSC Dip ABO Michel Neeff FRACS Jan Evans MBChB Brian Anderson PhD FANZCA FJFICM Colin Barber FRACS 《The Laryngoscope》2016,126(12):E416-E420
108.
Jennifer L. Williams Brian E. Kadera Andrew H. Nguyen V. Raman Muthusamy Zev A. Wainberg O. Joe Hines Howard A. Reber Timothy R. Donahue 《Journal of gastrointestinal surgery》2016,20(7):1331-1342
Background
Compared to the widely adopted 2–4 months of pre-operative therapy for patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC), our institution tends to administer a longer duration before considering surgical resection. Using this unique approach, the aim of this study was to determine pre-operative variables associated with survival.Methods
Records from patients with BR/LA PDAC who underwent attempt at surgical resection from 1992–2014 were reviewed.Results
After a median duration of 6 months of pre-operative treatment, 109 patients with BR/LA PDAC (BR 63, LA 46) were explored; 93 (85.3 %) underwent pancreatectomy. Those who received at least 6 months of pre-operative treatment had longer median overall survival (OS) than those who received less (52.8 vs. 32.1 months, P?=?0.044). On multivariate analysis, pre-operative treatment duration was the strongest predictor of survival (hazard ratio (HR) 4.79, P?=?0.043). However, OS was similar in those whose CA19-9 normalized regardless of whether they received more or less than 6 months of chemotherapy (71.4 vs. 101.8 months, P?=?0.930).Conclusions
Pre-operative CA19-9 decline can guide treatment duration in patients with BR/LA PDAC. We endorse 6 months of therapy except in those patients whose values normalize, where surgery can be considered after a shorter course.109.
Susceptible and protective associations of HLA DRB1*/DQB1* alleles and haplotypes with ischaemic stroke 下载免费PDF全文
V. Murali C. Rathika S. Ramgopal R. Padma Malini M. J. Arun Kumar V. Neethi Arasu K. Jeyaram Illiayaraja K. Balakrishnan 《International journal of immunogenetics》2016,43(3):159-165
Stroke has emerged as the second commonest cause of mortality worldwide and is a major public health problem. For the first time, we present here the association of human leucocyte antigen (HLA)‐DRB1*/DQB1* alleles and haplotypes with ischaemic stroke in South Indian patients. Ischaemic stroke (IS) cases and controls were genotyped for HLA‐DRB1*/DQB1* alleles by polymerase chain reaction sequence‐specific primers (PCR‐SSP) method. The frequencies of HLA class II alleles such as DRB1*04, DRB1*07, DRB1*11, DRB1*12, DRB1*13, DQB1*02 and DQB1*07 were high in IS patients than in the age‐ and gender‐matched controls, suggesting that the individuals with these alleles are susceptible to ischaemic stroke in South India. The frequencies of alleles such as DRB1*03, DRB1*10, DRB1*14, DQB1*04 and DQB1*05 were less in IS cases than in the controls, suggesting a protective association. Haplotypes DRB1*04‐DQB1*0301, DRB1*07‐DQB1*02, DRB1*07‐DQB1*0301, DRB1*11‐DQB1*0301 and DRB1*13‐DQB1*06 were found to be high in IS patients conferring susceptibility. The frequency of haplotype DRB1*10‐DQB1*05 was high in controls conferring protection. IS‐LVD and gender‐stratified analysis too confirmed these susceptible and protective associations. Thus, HLA‐DRB1*/DQB1* alleles and haplotypes strongly predispose South Indian population to ischaemic stroke. Further studies in different populations with large sample size or the meta‐analysis are needed to explain the exact mechanism of associations of HLA gene(s) with IS. 相似文献
110.
Reply to Tait,Alan; Voepel‐Lewis,Terri; Christensen,Robert; O'Brien,Louise, regarding their comment on ‘Utility of screening questionnaire,obesity, neck circumference,and sleep polysomnography to predict sleep‐disordered breathing in children and adolescents’ 下载免费PDF全文
Vidya T. Raman Mark Splaingard Dmitry Tumin Julie Rice Kris R. Jatana Joseph D. Tobias 《Paediatric anaesthesia》2016,26(10):1028-1029